Ads
related to: abbvie inc- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Lab Products & Equipment
Shop our huge portfolio of labware
equipment from leading brands.
- Solvent Center
Our Solvents include HPLC, ACS,
Anhydrous, Reagent Grade and more
- Stockroom Reagents
Solvents, Acids/Bases, Absorbents,
Filter Aids, Drying Agents and more
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Analytical/Chromatography
Browse our Analytical Reagents,
Standards, Microbiology and more.
- Sign In
Search results
Monitoring Abbvie Inc (ABBV) after recent insider movements – Knox Daily
Knox Daily· 2 days agoAbbvie Inc’s filing revealed that its EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas unloaded Company’s shares for reported $3.72 million on Mar 20 ’24.
AbbVie Inc. (NYSE:ABBV) to Post Q2 2024 Earnings of $3.01 Per Share, Zacks Research Forecasts
ETF DAILY NEWS· 6 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Analysts at Zacks Research lifted their Q2 2024 earnings estimates for shares of AbbVie in a research report issued ...
Abbvie Inc (NYSE: ABBV) Jumps 1.36%: What Could Be On The Way Going Forward? – Stocks Register
Stocks Register· 6 days agoAbbvie Inc (NYSE:ABBV) shares, rose in value on Wednesday, May 15, with the stock price up by 1.36% to the previous day’s close as strong demand from buyers ...
ABBV Stock Sees Surge of Approximately 2.08% in Last Five Days – Knox Daily
Knox Daily· 6 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Abbvie Inc shares valued at $3,716,757 were sold by ...
AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst - AbbVie...
Benzinga· 4 days agoCantor Fitzgerald initiates coverage on AbbVie with an Overweight rating and a $200 price target....
Earnings call: AbbVie projects robust growth and diversified pipeline
Investing.com· 7 days agoWith a growth platform that accounts for 80% of AbbVie's business, the company saw mid-teens growth...
Maryland Drug Board Advances Ozempic, Other Cost Reviews (1)
Bloomberg Law· 23 hours agoBlockbuster diabetes drugs Ozempic and Trulicity will be included in the Maryland prescription drug board’s first cost review, a monthslong process that will help the panel determine whether ...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 5 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Sarah Ketterer's Strategic Moves in Q1 2024: A Focus on UBS Group AG
GuruFocus.com via Yahoo Finance· 6 days agoThe stock traded at an average price of $135.87 during the quarter and has returned -8.41% over the...
Bernard Horn's Polaris Global Value Fund 1st-Quarter Letter: Loo
Guru Focus· 4 days agoGlobal equity markets enjoyed consecutive months of gains, with the MSCI World Index returning 8.88%...